[Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
D000328:Adult; D002354:Carteolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000009:adverse effects / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*
D011412:Propanolamines; D002354:Carteolol; D010869:Pindolol
Untersuchungen mit Carteolol bei der essentiellen Hypertonie. Dosis-Range-Studie und kontrollierte offene Prüfung im Vergleich zu Pindolol.